Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
537.9 USD | -0.23% | +1.68% | +14.26% |
02/05 | Factbox-Biggest cyber attacks in US healthcare sector | RE |
30/04 | Argus Raises Elevance Health's Price Target to $600 From $540 | MT |
Sales 2024 * | 172B 14,319B | Sales 2025 * | 182B 15,224B | Capitalization | 125B 10,461B |
---|---|---|---|---|---|
Net income 2024 * | 8.04B 672B | Net income 2025 * | 9.09B 759B | EV / Sales 2024 * | 0.83 x |
Net Debt 2024 * | 17.19B 1,435B | Net Debt 2025 * | 13.67B 1,141B | EV / Sales 2025 * | 0.76 x |
P/E ratio 2024 * |
15.6
x | P/E ratio 2025 * |
13.7
x | Employees | 1,04,900 |
Yield 2024 * |
1.16% | Yield 2025 * |
1.25% | Free-Float | 99.55% |
Latest transcript on Elevance Health, Inc.
1 day | +0.11% | ||
1 week | +2.32% | ||
Current month | +2.01% | ||
1 month | +8.38% | ||
3 months | +6.72% | ||
6 months | +17.66% | ||
Current year | +14.34% |
Managers | Title | Age | Since |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 20/17/20 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 06/23/06 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | 05/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 01/13/01 | |
Director/Board Member | 55 | 01/22/01 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 20/17/20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.22% | 17 M€ | +6.60% | - | |
2.36% | 1,085 M€ | +7.73% | - | |
2.07% | 8 M€ | +4.88% |
Date | Price | Change | Volume |
---|---|---|---|
13/24/13 | 538.8 | -0.07% | 50 578 |
10/24/10 | 539.2 | +0.11% | 841,374 |
09/24/09 | 538.6 | +0.98% | 456,566 |
08/24/08 | 533.4 | -0.53% | 807,651 |
07/24/07 | 536.2 | +1.18% | 692,867 |
Delayed Quote Nyse, May 11, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.34% | 125B | |
+16.34% | 98.97B | |
+4.82% | 41.51B | |
-26.70% | 40.44B | |
-1.86% | 20.78B | |
-25.95% | 2.62B | |
-20.67% | 1.31B | |
-13.87% | 407M |
- Stock Market
- Equities
- ELV Stock